Adaptive Pharmacogenomics, LLC

Clinical development for personalized medicine

Tuesday, February 7, 2012 | 4:53 PM

Personalized medicine in warfarin therapy

Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al., "Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry," appears in the March 2010 issue of the Journal of Molecular Diagnostics.
Feb 25, 2010 12:00 AMwww.eurekalert.org
© 2008 — 2012 Adaptive Pharmacogenomics, LLC